^
    5ms
    A Study of TY-1091 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1/2, N=248, Recruiting, TYK Medicines, Inc | Not yet recruiting --> Recruiting
    Enrollment open • Metastases
    |
    RET (Ret Proto-Oncogene)
    |
    RET fusion
    |
    TY-1091
    over1year
    A Study of TY-1091 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1/2, N=248, Not yet recruiting, TYK Medicines, Inc
    New P1/2 trial • Metastases
    |
    RET (Ret Proto-Oncogene)
    |
    RET fusion
    |
    TY-1091